Professor Dennis McGonagle explains the results of an EULAR 2024 late breaking abstract, the PRO-SPIRIT study, early (3-month) and maintained (12-month) comparative effectiveness of 5 different classes of advanced therapies in a large multinational cohort of real-world PsA patients.

Video: https://medicaldigest.org/scientific-contents/interview:early-and-maintained-comparative-effectiveness-5-different-classes-advanced-therapies-large-multinational-cohort-real-world-psa-patients

Professor Gerd Horneff explains the results of a late breaking abstract from EULAR 2024, effectiveness of canakinumab for first line steroid free treatment in systemic onset juvenile idiopathic arthritis/ juvenile Still’s disease.

Video: https://medicaldigest.org/scientific-contents/interview:what-new-osteoporosis-rheumatology

Professor Willem Lems share his thoughts on the latest developments in the diagnosis and therapy of osteoporosis as it pertains to the RMDs.

Video: https://medicaldigest.org/scientific-contents/interview:what-new-osteoporosis-rheumatology

Professor Anna-Maria Hoffmann-Vold gave us a review of the most recent data from the diagnosis to the management of interstitial lung disease in RMDs.

Video: https://medicaldigest.org/scientific-contents/interview:interstitial-lung-disease-diagnosis-management

Professor Rik Lories on the current challenges in prevention and treatment of psoriatic arthritis.

Video: https://medicaldigest.org/scientific-contents/interview:promising-directions-treatment-psoriatic-arthritis

Professor Francesco Del Galdo share his thoughts about EULAR Recommendations for the treatment of Systemic Sclerosis.

Video: https://medicaldigest.org/scientific-contents/interview:update-eular-recommendations-treatment-systemic-sclerosis

Professor David Isenberg shares an update on novel treatments for lupus and their clinical applications.

Video: https://medicaldigest.org/scientific-contents/interview:lupus-whats-horizon

Professor Denis Poddubnyy shared the results of AScalate trial, Secukinumab versus standard-of-care in axial spondyloarthritis, a randomized controlled open-label trial for treat-to-target outcomes.

Video: https://medicaldigest.org/scientific-contents/interview:secukinumab-versus-standard-care-axial-spondyloarthritis

Professor Roland Chapurlat shares his experiences on high risk osteoporosis combination terapies, on OP and CKD, as well on pregnancy and OP.

Video: https://medicaldigest.org/scientific-contents/interview:difficult-questions-osteoporosis

Professor Annette H. M. van der Helm van Mil share her thoughts about EULAR Recommendations on risk stratification in patients with arthralgia suspicious for progression to Rheumatoid Arthritis.

Video: https://medicaldigest.org/scientific-contents/interview:update-eularacr-project-risk-stratification-patients-arthralgia-suspicious-progression-ra